Top Page
BrainChip Holdings
(Sydney:BRN)
BrainChip Holdings (BRN) vs. iShares MSCI Australia ETF (EWA)
BrainChip Holdings Business Overview & Revenue Model
BrainChip Holdings Financial Statement Overview
| Breakdown | |||||
| TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 240.00K | 398.01K | 232.00K | 5.07M | 1.59M | 134.60K | Gross Profit |
| 100.00K | -134.91K | 91.44K | 4.59M | 1.30M | -195.72K | EBIT |
| -28.73M | 0.00 | -28.74M | -22.42M | -19.93M | -11.64M | EBITDA |
| -28.51M | -23.67M | -27.99M | -21.41M | -19.79M | -11.36M | Net Income Common Stockholders |
| -28.88M | -24.43M | -28.88M | -22.09M | -20.98M | -29.88M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 2.05M | 20.00M | 14.34M | 23.12M | 19.37M | 19.02M | Total Assets |
| 11.81M | 23.05M | 20.18M | 29.18M | 23.78M | 22.65M | Total Debt |
| 0.00 | 1.17M | 1.70M | 2.95M | 1.80M | 3.74M | Net Debt |
| -2.05M | -18.83M | -12.65M | -20.17M | -17.57M | -15.24M | Total Liabilities |
| 1.59M | 3.22M | 3.35M | 5.46M | 4.84M | 5.93M | Stockholders Equity |
| 10.21M | 19.83M | 16.83M | 23.72M | 18.94M | 16.72M |
| Cash Flow | Free Cash Flow | ||||
| -17.66M | -15.96M | -17.66M | -19.88M | ― | ― | Operating Cash Flow |
| -17.53M | 0.00 | -17.53M | -19.69M | -13.69M | -11.17M | Investing Cash Flow |
| -132.60K | -72.65K | -132.60K | -183.52K | ― | ― | Financing Cash Flow |
| 8.84M | 22.60M | 8.84M | 25.38M | 14.19M | 23.92M |
BrainChip Holdings Technical Analysis
BrainChip Holdings Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | AU$119.20M | 13.02 | 12.90% | 3.65% | 23.66% | -7.71% | |
62 Neutral | $11.80B | 10.37 | -7.29% | 2.91% | 7.39% | -7.96% | |
45 Neutral | $450.91M | ― | -133.28% | ― | 72.47% | 20.08% | |
| $84.75M | ― | -92.68% | ― | ― | ― | ||
73 Outperform | AU$663.44M | 101.69 | 11.59% | ― | 9.76% | -28.92% | |
39 Underperform | AU$383.97M | ― | -46.55% | ― | 905.48% | 10.02% | |
23 Underperform | AU$181.10M | ― | ― | -100.00% | 44.26% |
BrainChip Holdings Corporate Events
BrainChip Holdings Ltd announced a change in the director’s interest, specifically regarding Pia Turcinov, who disposed of 175,331 ordinary shares to meet Australian tax liabilities related to the historical vesting of performance rights. This transaction reflects the company’s adherence to regulatory requirements and transparency in director dealings, potentially impacting investor perceptions and stakeholder confidence.
BrainChip Holdings Ltd announced a change in the director’s interest, with Director Antonio Jose Florindo Viana disposing of 130,000 ordinary shares valued at $27,950. This transaction was conducted to facilitate the payment of US Federal and State Taxes related to the vesting of Restricted Stock Units. The change reflects the director’s financial management strategy and does not indicate a shift in the company’s operational or strategic direction.
BrainChip Holdings Ltd announced a change in the director’s interest notice, with Director Duy-Loan Thi Le acquiring 697,674 Ordinary Shares as a result of the vesting of Restricted Stock Units. This change reflects an increase in her direct and indirect holdings in the company, with no cash consideration involved. The announcement highlights the company’s ongoing commitment to aligning its leadership’s interests with shareholder value, potentially impacting its market perception and stakeholder confidence.
BrainChip Holdings Ltd has announced a change in the director’s interest, specifically regarding Pia Turcinov’s holdings. On May 23, 2025, Ms. Turcinov acquired 766,799 Ordinary Shares through the vesting of Performance Rights, while disposing of 69,125 Performance Rights. This change reflects a strategic adjustment in the director’s shareholding, potentially impacting the company’s stakeholder dynamics and market perception.
BrainChip Holdings Ltd has announced a change in the interests of its director, Antonio Jose Florindo Viana, in the company’s securities. The change involves the conversion of 697,674 Restricted Stock Units into the same number of Ordinary Shares, resulting in Mr. Viana holding a total of 3,130,018 Fully Paid Ordinary Shares. This adjustment reflects the vesting of Restricted Stock Units under the company’s Employee Share Plan Trust, with no cash consideration involved. The shares were valued at $0.22 per share as of May 22, 2025. This change in director’s interest is part of the company’s ongoing governance and compliance with ASX regulations.
BrainChip Holdings Ltd announced the cancellation of a previous notification regarding the issue, conversion, or payment of unquoted equity securities. This decision was made because service rights have vested but do not automatically convert to shares unless the holder chooses to exercise them, impacting the company’s equity management strategy.
BrainChip Holdings Ltd has announced the issuance of 2,093,022 fully paid ordinary securities as of May 23, 2025. This move indicates the company’s strategic financial maneuvers to potentially enhance its market position and operational capabilities, reflecting a proactive approach to leveraging its equity for growth and development. The issuance of these securities may have implications for stakeholders, suggesting an expansion or strengthening of the company’s financial foundation.
BrainChip Holdings Ltd has announced the issuance of 1,395,348 ordinary fully paid securities as of May 23, 2025. This move involves the conversion of unquoted options or other convertible securities, which could potentially impact the company’s financial structure and market positioning by increasing its capital base.
BrainChip Holdings Ltd has announced a change in the director’s interest, specifically regarding Sean Hehir, who has acquired 7,545,307 Restricted Stock Units, increasing his total holdings to 11,918,679 units. This change, approved by shareholders at the recent Annual General Meeting, reflects the company’s ongoing commitment to aligning its leadership’s interests with its strategic goals, potentially impacting its market positioning and stakeholder confidence.
BrainChip Holdings Ltd announced the issuance of 7,545,307 restricted stock units under an employee incentive scheme. These securities are unquoted and subject to transfer restrictions until the specified conditions are met, reflecting the company’s commitment to incentivizing its workforce and aligning their interests with corporate growth objectives.
BrainChip Holdings Ltd announced the results of its Annual General Meeting, where several key resolutions were voted on. Notably, the adoption of the Remuneration Report was not carried, marking a first strike under the Corporations Act 2001, while the re-election of directors and other resolutions were successfully passed. This outcome may influence the company’s governance and stakeholder relations moving forward.
At the 2025 Annual General Meeting, BrainChip Holdings Ltd’s CEO and Chairman highlighted the company’s robust product roadmap, which positions it well in the current market and anticipates future trends. The company has undergone significant changes to improve its product offerings, leading to increased market engagements and a strong outlook for future growth, reflecting a newfound confidence in its market strategy.
BrainChip Holdings Ltd has released its top 50 shareholders list as of April 28, 2025, showcasing the distribution of its fully paid ordinary shares. The list highlights significant stakeholders, including Mr. Peter Adrian Van Der Made and BNP Paribas Nominees Pty Ltd, among others, indicating the company’s shareholder structure and potential influences on its strategic decisions.
BrainChip Holdings has made significant strides in the first quarter of 2025, with key developments including a contract awarded to Frontgrade Gaisler by the Swedish National Space Agency to commercialize a neuromorphic System on Chip for space applications, integrating BrainChip’s Akida™ technology. Additionally, BrainChip has entered into a subcontractor agreement with Raytheon for a U.S. Air Force Research Laboratory contract, collaborated with Onsor Technologies for a seizure prediction wearable, and partnered with Information Systems Laboratories to advance AI-based radar solutions. The company is also considering redomiciling to the United States to potentially enhance shareholder value.
BrainChip Holdings Ltd has announced a change in the director’s interest, specifically involving Peter Van Der Made, who disposed of 333,333 fully paid ordinary shares. The shares were gifted to ShareGift Australia and subject to a charity nomination to ADRA Australia, with the transaction managed through an on-market trade process. This move reflects the company’s commitment to corporate social responsibility and may influence its reputation positively among stakeholders.
BrainChip Holdings Ltd announced the issuance of 331,941 ordinary fully paid securities as of March 31, 2025. This move signifies a strategic step in strengthening the company’s financial position and potentially enhancing its market presence, reflecting its ongoing commitment to growth and innovation in the AI technology sector.
BrainChip Holdings Ltd announced the cessation of certain securities, specifically options and restricted stock units, due to unmet conditions. This development may impact the company’s capital structure and could have implications for stakeholders, as it reflects on the company’s ability to meet certain financial or operational conditions.
BrainChip Holdings Ltd is set to present its future Technology Roadmap, highlighting advancements in its Akida IP and target applications. The presentation, led by Chief Development Officer Dr. Jonathan Tapson, will provide insights into the company’s development plans and market requirements, potentially impacting BrainChip’s industry positioning and stakeholder interests.
BrainChip Holdings Ltd has announced its 2025 Annual General Meeting, highlighting the company’s commitment to aligning executive compensation with shareholder interests. The Board has designed a remuneration strategy that includes a flexible and holistic approach to attract top talent globally, with a focus on achieving high financial targets. Despite falling short of 2024 goals, the company continues to refine its compensation programs to ensure they are competitive and aligned with market practices, reflecting shareholder feedback and confidence in BrainChip’s long-term growth prospects.